Real-World Skin Clearance and Quality of Life with risankizumab in Patients with Psoriasis with Moderate Skin Involvement and Those Eligible for Systemic Therapy Per International Psoriasis Council Classification.

Saved in:
Bibliographic Details
Title: Real-World Skin Clearance and Quality of Life with risankizumab in Patients with Psoriasis with Moderate Skin Involvement and Those Eligible for Systemic Therapy Per International Psoriasis Council Classification.
Authors: Strober, Bruce1,2 (AUTHOR) brucestrober30@me.com, Patel, Manish3 (AUTHOR), Kaldas, Mark I.3 (AUTHOR), St. John, Greg3 (AUTHOR), Photowala, Huzefa3 (AUTHOR), Sima, Adam P.4 (AUTHOR), Eckmann, Thomas4 (AUTHOR), Beeghly, Alicia4 (AUTHOR), Armstrong, April5 (AUTHOR)
Source: Dermatology & Therapy. Sep2025, Vol. 15 Issue 9, p2409-2421. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-025-01474-3